Nonseminomatous germ cell tumor after chemotherapy with residual mass invading the spine: part 2.
Berglund
Ryan K
RK
Section of Urologic Oncology, Glickman Urological Institute, Cleveland, OH 44195, USA.
Lyden
Sean P
SP
Tsai
Eve C
EC
Lieberman
Isador
I
Klein
Eric A
EA
D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000556:secondary*; D018450:Disease Progression; D019008:Drug Resistance, Neoplasm; D006801:Humans; D008297:Male; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local; D018365:Neoplasm, Residual / Q000175:diagnosis / Q000601:surgery; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy*; D013125:Spinal Neoplasms / Q000556:secondary*; D013724:Teratoma / Q000188:drug therapy / Q000601:surgery; D013736:Testicular Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents